China Evergrande New Stock (OTC:EVGRF), Trade Ideas

China Evergrande New Energy Vehicle Group Ltd is engaged in the technology research and development, production, and sales of new energy vehicles. It is also involved in community health management, international hospitals, and the elderly care and rehabilitation business. The company's operating segments include Health Management and New Energy Vehicle. It generates most of its revenues from Health Management segment.

China Evergrande

Asia

News

Global

Markets

Media

General

EGRNQ

EVGRF

China&#39;s Evergrande Shares Halted As Hong Kong Court Orders Liquidation Of World&#39;s Most Indebted Developer With Over $300B In Liabilities

Economics

Real Estate

BABA

CTRYF

TCEHY

XPEV

Shares in Hong Kong ended the week lower after a rout of selling among tech names and as property continues to skewer markets.

Investors also focused on bank earnings next week which they expect to be lower due to tightening margins. China’s Central Bank pumped a record stimulus into the banking system to keep short-term prime loan rates steady amid the recent credit woes.

Hong Kong Stocks End The Week In A Rout As China&#39;s Central Bank Pumps $100 Billion Into Banking System Ahead Of Long Weekend

Penny Stocks

CTRYY

LNGPF

SZENF

Two of China’s largest property developers, Country Garden Holdings Limited (OTC: CTRYF) (OTC: CTRYY) and China Evergrande Group (OTC: EVGRF) are f

China&#39;s Largest Property Developer Misses Its First Bond Payment, While Another Heads To Court With Creditors Next Week

CHINA EVERGRANDE NEW EGY by CHINA EVERGRANDE NEW ENERGY VEH GROUP LTD.

China Evergrande New Energy Vehicle Group Ltd

Barclays analyst Matthew Bouley maintains Anywhere Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HOUS#NYSE">HOUS</a>) with a Underweight and lowers the price target from $5 to $4.5.

Price Target

Analyst Ratings

HOUS

Barclays Maintains Underweight on Anywhere Real Estate, Lowers Price Target to $4.5

WIIM

SNAP

Snap shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 revenue guidance above estimates. Also, the company reported a year-over-year increase in Q1 daily active users.

Stifel analyst J. Bruce Chan downgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Buy to Hold and lowers the price target from $53 to $47.

Downgrades

Stifel Downgrades Knight-Swift to Hold, Lowers Price Target to $47

Barclays maintains Accolade (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACCD#NASDAQ">ACCD</a>) with a Equal-Weight and lowers the price target from $13 to $11.

ACCD

Barclays Maintains Equal-Weight on Accolade, Lowers Price Target to $11

ABBV

AbbVie shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY24 adjusted EPS guidance above estimates.

HSBC analyst Mohammed Khallouf upgrades Snap (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNAP#NYSE">SNAP</a>) from Reduce to Hold.

Upgrades

HSBC Upgrades Snap to Hold

&#8220;Mad Money&#8221; host Jim Cramer pointed out the disproportionate coverage of Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38381758/jim-cramer-weighs-in-after-iphone-sales-reportedly-plummet-19-in-china-in-q1-anothe">&#8220;losing leadership&#8221;</a> compared to Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google and Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) post their &#8220;spectacular quarters.&#8221;
What Happened: On Friday, Cramer took to X, formerly Twitter, to express his observation. He noted the abundance of articles discussing Apple&#8217;s recent struggles with <a href="https://www.benzinga.com/markets/equities/24/03/37872817/apple-says-dangerous-doj-lawsuit-threatens-who-we-are-vows-to-fight-against-it">antitrust regulations</a> and its latest product, Vision Pro, while <a href="https://www.benzinga.com/news/earnings/24/04/38445001/alphabet-q1-earnings-revenue-beat-eps-beat-70b-buyback-first-ever-dividend-ai-leadership-and-more">Google</a> and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38453639/another-picasso-like-performance-top-tech-analyst-praises-satya-nadella-says-micros">Microsoft&#8217;s remarkable quarterly results</a> barely made the news.
His post came after Alphabet and Microsoft released their earnings reports, both of which exceeded analyst expectations, while Apple&#8217;s iPhone sales in China plunged.
&#8220;There are hundreds of articles about Apple losing leadership but Google and Microsoft can barely buy an inch of ink after some spectacular quarters&#8230;&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">There are hundreds of articles about Apple losing leadership but Google and Microsoft can barely buy an inch of ink after some spectacular quarters&#8230;
&mdash; Jim Cramer (@jimcramer) <a href="https://twitter.com/jimcramer/status/1783774623689011385?ref_src=twsrc%5Etfw">April 26, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/04/38392548/ups-earnings-show-the-weight-of-170-000-salaries-while-it-learns-to-navigate-shipping-slump?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">UPS Earnings Show The Weight Of $170,000 Compensation While It Learns To Navigate Shipping Slump</a>
Apple&#8217;s iPhone sales in China nosedived 19.1% in the first three months of 2024, with its market share witnessing a significant decline to 15.7% from 19.7% a year ago, according to data from Counterpoint Research.
This is Apple&#8217;s worst performance since 2020, largely due to the impact of Huawei Technologies Co.'s new <a href="https://www.benzinga.com/markets/equities/24/04/38308198/apples-falling-iphone-sales-have-another-challenge-to-deal-with-as-huawei-launches-new-phones" target="_blank" rel="noreferrer noopener">product launches</a> in the premium segment. Huawei's sales surged by 70% in the same period.
Why It Matters: Wall Street is eagerly anticipating <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38378204/apple-is-a-top-stock-pick-for-2024-analyst-says-4-catalysts-to-look-for-in-next-ear">Apple&#8217;s upcoming Q2 earnings</a> report, with analysts highlighting the stock&#8217;s promising outlook. Meanwhile, <a href="https://www.benzinga.com/news/earnings/24/04/38444199/microsoft-q3-earnings-revenue-beat-eps-beat-new-era-of-ai-transformation-and-more">Microsoft</a> and Alphabet have already reported impressive Q3 and Q1 earnings, respectively, beating both top and bottom-line estimates for five consecutive quarters.
Price Action: On Thursday, Apple closed at $169.89, Alphabet Inc. at $157.95, and Microsoft at $399.04, as per<a href="https://pro.benzinga.com"> Benzinga Pro</a>.
Read Next: <a href="https://www.benzinga.com/markets/equities/24/04/38384714/whats-going-on-with-trump-media-technology-stock-on-tuesday?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">What&#8217;s Going On With Trump Media &amp; Technology Stock On Tuesday?</a>
Image via Shutterstock
<div style="font-family: 'Lato', sans-serif">
<div>
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by Benzinga Neuro, Edited by 
 <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Pooja Rajkumari</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>
</div>

Analyst Color

Equities

Tech

AAPL

GOOG

GOOGL

MSFT

Jim Cramer Says 'There Are Hundreds Of Articles' About Apple Losing Top Spot In China: 'Google And Microsoft Can Barely Buy An Inch Of Ink After Some Spectacular Quarters'

Charter currently expects full year 2024 capital expenditures to total between&nbsp;$12.2 billion&nbsp;and&nbsp;$12.4 billion, including line extensions capital expenditures of approximately&nbsp;$4.5 billion&nbsp;and network evolution spend of approximately&nbsp;$1.6 billion, compared to&nbsp;$4.0 billion&nbsp;and&nbsp;$0.9 billion, respectively, in 2023.

Guidance

CHTR

Charter Communications Reiterated 2024 Capex Outlook of $12.2B–$12.4B

Software giant Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) reported Thursday after the market close <a href="https://www.benzinga.com/news/earnings/24/04/38444199/microsoft-q3-earnings-revenue-beat-eps-beat-new-era-of-ai-transformation-and-more">strong third-quarter results,</a> sending its stock higher. 
On Cloud Nine: Microsoft attributed the strong quarterly performance, primarily to its Cloud business. &#8220;This quarter Microsoft Cloud revenue was $35.1 billion, up 23% year-over-year, driven by strong execution by our sales teams and partners,&#8221; CFO Amy Hood said in a statement.
Microsoft&#8217;s Azure public cloud and other cloud services saw both GAAP and constant currency revenue growth of 31%.
Speaking on the earnings call, CEO Satya Nadella said, &#8220;Azure again took share as customers use our platforms and tools to build their own AI solutions.&#8221; He also noted that more than 65% of the Fortune 500 now use Azure OpenAI service.&nbsp;
Commenting on the Azure performance, Piper Sandler&#8217;s Brent Bracelin said the 31% growth exceeded the guidance for a 28% increase and reinforced his bullish view that Microsoft remained &#8220;best-positioned to monetize robust AI secular tailwinds while capitalizing on a first-mover advantage.&#8221;
Bracelin estimated that Azure AI contributed over a $5 billion annualized run rate. 
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best Artificial Intelligence Stocks</a>
Ancillary Beneficiaries: Calling Snowflake, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) and MongoDB, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>) as &#8220;Azure upside derivatives to watch,&#8221; Bracelin said these two companies have the most indirect exposure to consumption activity trends across the Cloud Titan cohort.
&#8220;Majority of revenue for SNOW is consumption-based while about 66% of revenue mix for MDB is consumption-based,&#8221; he said.
Bozeman, Montana-based Snowflake is a data-as-a-service company — backed by <a href="https://www.benzinga.com/news/large-cap/23/08/33611401/in-ai-we-trust-warren-buffett-sent-46-7-of-berkshire-hathaways-portfolio-there">Warren Buffett&#8216;s Berkshire Hathway</a> — offering a cloud-based data storage and analytics service and New York-based MongoDB is a provider of commercial support for the source-available database engine MongoDB.
In premarket trading on Friday, Snowflake rose 3.19% to $157.37&nbsp;and MongDB climbed 3.55% to $379.13, according to <a href="https://benzinga.grsm.io/lxquj26b2sag">Benzinga Pro data.</a> Microsoft rallied 4.34% to $416.34.
Read Next: <a href="https://www.benzinga.com/news/earnings/24/04/38455462/wall-street-futures-ride-high-on-microsoft-alphabet-cheer-but-will-inflation-data-burst-the-bubble-">Wall Street Futures Ride High On Microsoft, Alphabet Cheer, But Will Inflation Data Burst The Bubble? Why This Analyst Thinks Bull Run Isn&#8217;t Over Yet</a>
Photo via Shutterstock

Long Ideas

Trading Ideas

SNOW

Microsoft's Azure Strength Could Rub Off On This Warren Buffett-Backed Stock And Another Big Cloud Player, Says Analyst

HCA Healthcare shares are trading lower. The company reported Q1 financial results.

Raymond James analyst Brian Gesuale upgrades Kratos Defense &amp; Security (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTOS#NASDAQ">KTOS</a>) from Outperform to Strong Buy and raises the price target from $20 to $27.

KTOS

Raymond James Upgrades Kratos Defense & Security to Strong Buy, Raises Price Target to $27

Enabled by high-capacity batteries, this key technology seeks to enhance security for users, ensure the conformity of all system components, and deliver an elevated boating experience.

VMAR

Vision Marine Technologies Says It Filed Patent For Advanced System Communication Encryption In E-Motion Powertrain

Needham analyst Laura Martin reiterates Roku (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>) with a Buy and maintains $100 price target.

Reiteration

ROKU

Needham Reiterates Buy on Roku, Maintains $100 Price Target

Earnings

Large Cap

Health Care

AbbVie Is Raising Its 2024 Adjusted EPS Guidance From $10.97-$11.17 To $11.13-$11.33, Which Includes An Unfavorable Impact Of $0.08 Per Share Related To Acquired IPR&D And Milestones Expense, Versus Consensus Of $11.12

For the first quarter, the Company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss and Adjusted EBITDA loss between $(8.2) - $(7.0) million and $(1.0) - $(0.7) million, respectively (see definition of this non-GAAP measure and reconciliation to GAAP, below). The year-over-year revenue increase was primarily driven by strong organic growth due to our Dynamic Audience Activation Platform (DAAP) as well as from our October 2023 acquisition of Medicx Health.
Steve Silvestro, OptimizeRx President commented, "The momentum from the fourth quarter has carried into the first quarter of 2024 with the signing of 9 new DAAP deals. Current industry trends favor our approach with pharma looking to partner with scalable platforms that have agile precision-marketing capabilities which at its core is what our AI enabled platform delivers."
"Our commercial integration strategy between OptimizeRx and Medicx is also progressing ahead of our expectations, with numerous new cross-sell opportunities in late-stage negotiations. The integration of the two businesses is ahead of schedule and we are optimistic about our performance. With the addition of Medicx, we stand out as the only scalable platform with both HCP and direct-to-consumer reach. This unique positioning enhances our ability to cross-sell and upsell, unlocking significant value. We estimate the potential opportunity with existing brands alone to be nearly $2.8 billion, with even greater potential for brands we don't yet support. This favorable environment strengthens our confidence in meeting or exceeding our financial targets."

OPRX

OptimizeRx Corporation Says 1Q24 Revenue Expected To Grow Over 40% YoY And Come In Between $18.5M-$19.2M Vs. $17.03M Estimate; Company Says DAAP Adoption And Cross Selling Activities Are Tracking Ahead Of Internal Expectations

HC Wainwright &amp; Co. analyst Edward White reiterates Syndax Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDX#NASDAQ">SNDX</a>) with a Buy and maintains $41 price target.

SNDX

HC Wainwright & Co. Reiterates Buy on Syndax Pharmaceuticals, Maintains $41 Price Target

Mizuho analyst Vijay Rakesh maintains Intel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) with a Buy and lowers the price target from $55 to $45.

INTC

Mizuho Maintains Buy on Intel, Lowers Price Target to $45

AbbVie (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $2.23 by 3.59 percent. This is a 6.1 percent decrease over earnings of $2.46 per share from the same period last year. The company reported quarterly sales of $12.310 billion which beat the analyst consensus estimate of $11.923 billion by 3.25 percent. This is a 0.70 percent increase over sales of $12.225 billion the same period last year.

Earnings Beats

AbbVie Q1 2024 Adj EPS $2.31 Beats $2.23 Estimate, Sales $12.310B Beat $11.923B Estimate

Although U.S. stocks closed lower on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Biohaven</h3>
<ul>
<li>The Trade: Biohaven Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BHVN#NYSE">BHVN</a>) Director Gregory Bailey <a href="https://www.benzinga.com/quote/BHVN/analyst-ratings">acquired a total of 25,503 shares</a> at an average price of $39.18. To acquire these shares, it cost around $999,169.</li>
<li>What's Happening: On April 18, Biohaven priced a 5.609 million share offering at $41 per share.</li>
<li>What Biohaven Does: Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology.</li>
</ul>
<h3 class="wp-block-heading">authID</h3>
<ul>
<li>The Trade: authID Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUID#NASDAQ">AUID</a>) 10% owner Stephen Jeffrey Garchik acquired a total of 12,000 shares at an average price of $6.85. To acquire these shares, it cost around $82,200.</li>
<li>What's Happening: On March 20, authID posted a narrower FY23 loss.</li>
<li>What authID Does: AuthID Inc is a company engaged in ensuring cyber-savvy enterprises &#8220;Know Who&#8217;s Behind the Device&#8221; for every customer or employee login and transaction.</li>
</ul>
Don&#8217;t forget to check out our <a href="https://www.benzinga.com/premarket/">premarket coverage here</a>
<h3 class="wp-block-heading">Frequency Electronics</h3>
<ul>
<li>The Trade: Frequency Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FEIM#NASDAQ">FEIM</a>) Director Russell M Sarachek <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,602 shares</a> at an average price of $9.51. To acquire these shares, it cost around $15,235.</li>
<li>What's Happening: On March 14, Frequency Electronics posted a narrower third-quarter loss.</li>
<li>What Frequency Electronics Does: Frequency Electronics Inc is engaged in the design, development, and manufacture of high-precision timing, and frequency control products for space, air, sea, and terrestrial applications.</li>
</ul>
<h3 class="wp-block-heading">Bank7</h3>
<ul>
<li>The Trade: Bank7 Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSVN#NASDAQ">BSVN</a>) Director Edward Patrick Gray <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 1,000 shares</a> at an average price of $27.25. The insider spent around $27,254 to buy those shares.</li>
<li>What's Happening: On April 12, Bank7 posted upbeat quarterly earnings.</li>
<li>What Bank7 Does: Bank7 Corp is a full-service commercial bank focused on providing customers with exceptional service and meeting their banking needs through a wide variety of commercial and retail financial services.</li>
</ul>
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38452338/microsoft-alphabet-and-3-stocks-to-watch-heading-into-friday">Microsoft, Alphabet And 3 Stocks To Watch Heading Into Friday</a>

Insider Trades

Pre-Market Outlook

AUID

BHVN

BSVN

FEIM

Around $1M Bet On Biohaven? Check Out These 4 Stocks Insiders Are Buying

AMZN

Amazon.com shares are trading higher following strong earnings from large-cap tech companies.

UAE-based auto maker NWTN acquires 25.7% stake in China Evergrande's EV unit for $500M

Evergrande gets last chance for debt deal to avert liquidation; stock hits record low

Evergrande gets last chance to avert liquidation; stock hits record low

China Evergrande said to propose last-minute debt plan to avert liquidation

China Evergrande winding-up hearing pushed to January

CHIR

EGRNF

EVGPF

LPHHF

NWTN

Legal

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of China Evergrande Group - EVGRF

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of China Evergrande Group - EVGRF

China Evergrande New